Lifeaz key facts
as of Oct 2026- Developer of a defibrillator device designed to empower people to save lives.
- Lifeaz is valued at approximately $60.9M as of Oct 2026 (last reported valuation).
- It has raised $23.4M; the latest was Later Stage VC ($15.3M) in Feb 2026.
- Notable investors include Kima Ventures, XAnge, Siparex, GO Capital, Mirova — 10 tracked in total.
- Status: Privately Held (backing).
Lifeaz's last reported valuation, Feb 2026. Nothing priced has surfaced since.
- ·Watch Lifeaz: the Monday email on marks, rounds and moves
Lifeaz funding rounds
No funding rounds for Lifeaz are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Lifeaz valuation
Lifeaz's last reported valuation was $60.9 million in Feb 2026. No priced round, secondary trade or fund mark has surfaced since.
Lifeaz investors
10 investors are on record for Lifeaz, including Kima Ventures, XAnge, Siparex and GO Capital.
About Lifeaz
Developer of a defibrillator device designed to empower people to save lives. The company's defibrillators provide vocal instructions for usage and enable the user to place the electrodes on the patient's chest, analyze the cardiac rhythm, and decide what therapy to deliver, enabling individuals and companies to be prepared for emergencies and effectively administer aid.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2015
- Employees
- 43
- Website
- lifeaz.co/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.